Lenart Lukáš M.Sc.

E-mail: lukas.lenart01@upol.cz

Groups: BACHELOR STUDENT, DOCTORAL STUDENT, LEM, MASTER STUDENT

Molecular basis of rare diseases and molecular targets

Specialization: Molecular and Translational Medicine

Supervisor: Hajdúch Marián M.D., Ph.D.

Status: Ongoing from 2023.

CRISPR/Cas9 as a tool for the development of a cystic fibrosis model for high throughput screening of compounds

Supervisor: Ondra Martin M.Sc.

Status: Graduated from 2021 to 2023.

Analysis of antiparasitic activity of novel compounds

Supervisor: Schadich Ermin Ph.D.

Status: Graduated from 2018 to 2021.

ZAJDEL, P., V. LOBAZ, M. ONDRA, R. KONEFAL, O. MORAVEC, O. POP GEORGIEVSKI, J. PANEK, D. KALITA, B. SIKORA DOBROWOLSKA, L. LENART, M. HAJDÚCH, M. HRUBY, M. PRUSZYNSKI

May the target be with you: polysaccharide-coated upconverting nanoparticles for macrophage targeting. Nanoscale. 2025, 17(43), 25120-25135, ISSN: 2040-3364 , PMID: 41123462, PDF.

ONDRA, M., L. LENART, A. CENTORAME, D. DUMUT, A. HE, S. ZAIDI, J. HANRAHAN, J. DE SANCTIS, D. RADZIOCH, M. HAJDÚCH

CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane. Life Science Alliance. 2023, 7(1), e202302045, ISSN: 2575-1077, PMID: 37918963,

Lenart Lukáš M.Sc.

Doctoral training

Master training

Bachelor training

Journals